Location: London, United Kingdom
CIK: 0001687444 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Mar 10, 2020
Total Value: $31.57M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHINA BIOLOGIC PRODS HLDGS I | 207,382 | $24.14M | 76.5% | $115.27 | — | COM | G21515104 |
| — | QIAGEN NV | 180,455 | $6.099M | 19.3% | $33.80 | — | SHS NEW | N72482123 |
| — | BRISTOL MYERS SQUIBB CO | 442,340 | $1.331M | 4.2% | $3.01 | — | RIGHT 99/99/9999 | 110122157 |